Med Shop Total Care Inc.
Letter data
- Company
- Med Shop Total Care Inc.
- Recipient
- Jennifer D. Yoakum | Co-Owner and Pharmacist-In-Charge | Med Shop Total Care Inc. | 479 E. Loop 281 | Longview | , | TX | 75605-7939 | United States | jyoakum@medshoptotalcare.com
- Issue date
- 2023-10-11
- Posted date
- Not available
- FDA office
- Office of Pharmaceutical Quality Operations, Division II
- Subject
- Not available
- Product
- Drugs
- CMS ID
- 628182
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Med Shop Total Care Inc.
MARCS-CMS 628182 —
October 11, 2023
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Drugs
Recipient:
Recipient Name
Jennifer D. Yoakum
Recipient Title
Co-Owner and Pharmacist-In-Charge
Med Shop Total Care Inc.
479 E. Loop 281
Longview
,
TX
75605-7939
United States
jyoakum@medshoptotalcare.com
Issuing Office:
Office of Pharmaceutical Quality Operations, Division II
United States
Dear Ms. Yoakum:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letters (Case #581309) dated July 30, 2019, and (Case #628182) dated March 18, 2022. Based on our evaluation, it appears that you have adequately addressed the violations contained in these warning letters.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Ronda Loyd-Jones
Director, Compliance Branch
Office of Pharmaceutical Quality Operations,
Division II
Content current as of:
10/24/2023
Regulated Product(s)
Drugs